Literature DB >> 18958748

Immune re-education following autologous hematopoietic stem cell transplantation.

Sofia Abrahamsson1, Paolo A Muraro.   

Abstract

The encounter with different environmental antigens during immune maturation from childhood through early adulthood could play a role in the development of autoimmune disease in individuals with a susceptible genetic background. Autologous haematopoietic stem cell transplantation (HSCT) is an experimental treatment for autoimmunity that could offer a second possibility to correct for an aberrant immune reactivity. The premise is that eradication of the existing and pathogenic immune repertoire, in combination with the reinfusion of precursor cells, could reset the immunological clock to an earlier, latent phase of disease. Re-education of the adaptive immune system would occur during the reconstitution of cells under extreme lymphopenia, in which the antigenic priming takes place with a different sequence and timing than during the previous immunological history of the individual, resulting in a different immune repertoire. In this article, we discuss different mechanisms that could contribute to the development of tolerance during immune re-education and address the role of immune renewal and the qualitative reshaping of immunological memory.

Entities:  

Mesh:

Year:  2008        PMID: 18958748     DOI: 10.1080/08916930802197081

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  9 in total

1.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

Review 2.  Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?

Authors:  J E Vaughn; F Anwer; H J Deeg
Journal:  Vox Sang       Date:  2015-07-14       Impact factor: 2.144

3.  Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; A F Ferreira; E P L Gasparotto; S Kashima; D T Covas; C T Guerreiro; D G Brum; A A Barreira; J C Voltarelli; B P Simões; M C Oliveira; F A de Castro; K C R Malmegrim
Journal:  Clin Exp Immunol       Date:  2016-12-23       Impact factor: 4.330

Review 4.  Hematopoietic stem cell transplantation for systemic lupus erythematosus.

Authors:  Alberto M Marmont du Haut Champ
Journal:  Clin Dev Immunol       Date:  2012-08-30

5.  Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.

Authors:  Dominique Farge; Lucas C M Arruda; Fanny Brigant; Emmanuel Clave; Corinne Douay; Zora Marjanovic; Christophe Deligny; Guitta Maki; Eliane Gluckman; Antoine Toubert; Helene Moins-Teisserenc
Journal:  J Hematol Oncol       Date:  2017-01-19       Impact factor: 17.388

6.  Tolerance induction with donor hematopoietic stem cell infusion in kidney transplantation: a single-center experience in China with a 10-year follow-up.

Authors:  Xuanchuan Wang; Cheng Yang; Linkun Hu; Zheng Wei; Qunye Tang; Bing Chen; Yuan Ji; Ming Xu; Zhaochong Zeng; Ruiming Rong; Tongyu Zhu
Journal:  Ann Transl Med       Date:  2020-11

7.  Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.

Authors:  Patrick-Pascal Strunz; Matthias Froehlich; Michael Gernert; Eva Christina Schwaneck; Anna Fleischer; Ann-Christin Pecher; Hans-Peter Tony; Joerg Christoph Henes; Marc Schmalzing
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

Review 8.  Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis.

Authors:  Marianna Y Kawashima-Vasconcelos; Maynara Santana-Gonçalves; Djúlio C Zanin-Silva; Kelen C R Malmegrim; Maria Carolina Oliveira
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

Review 9.  Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.

Authors:  Nicoletta Del Papa; Francesca Pignataro; Eleonora Zaccara; Wanda Maglione; Antonina Minniti
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.